Pavord, Ian D.Mathieson, NicolaScowcroft, AnnaPedersini, RiccardoPrice, David B2017-04-052017-04-052017Pavord, I D, Mathieson, N, Scowcroft, A, Pedersini, R & Price, D B 2017, 'The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β2-agonists in the United Kingdom : a cross-sectional analysis', npj Primary Care Respiratory Medicine, vol. 27, 17. https://doi.org/10.1038/s41533-017-0014-1http://hdl.handle.net/2164/8464This study was sponsored by Boehringer Ingelheim Ltd UK, which was involved in all stages of the study conduct and analysis and also funded all costs associated with the development of the manuscript. The authors acknowledge Kantar Health and Errol J Philip for providing medical writing support. Editorial assistance and medical writing support was also provided by Michelle Rebello, PhD, and Suchita Nath-Sain, PhD, of Cactus Communications. This study was sponsored by Boehringer Ingelheim Ltd., UK, which also funded all costs associated with the development of the manuscript. Author Correction, npj Primary Care Respiratory Medicine 27, Article number: 65 (2017) doi:10.1038/s41533-017-0063-5, 05 December 2017 Correction to:npj Primary Care Respiratory Medicine (2017); doi:10.1038/s41533-017-0014-1; Published 09 March 20179470530engasthmahealth care economicsquality of lifeR MedicineRThe impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β2-agonists in the United Kingdom : a cross-sectional analysisJournal article10.1038/s41533-017-0014-1https://doi.org/10.1038/s41533-017-0063-527